Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gibb

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2012
Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasiaEwan A Gibb, Daiana D Becker-Santos, Katey S S Enfield, et al.
Urologic Oncology|July 24, 2021
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibitionAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapyJoep J de Jong, Moritz J Reike, Yair Lotan, et al.
Genitourinary Medicine|April 1, 1997
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study GroupN J Bodsworth, R J Crooks, S Borelli, et al.
Scientific Reports|March 13, 2021
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancerFriedemann Krentel, Franziska Singer, María Lourdes Rosano-Gonzalez, et al.
British Journal of Cancer|October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicityA Gibb, A Greystoke, M Ranson, et al.
JCI Insight|February 9, 2018
TAK1 regulates skeletal muscle mass and mitochondrial functionSajedah M Hindi, Shuichi Sato, Guangyan Xiong, et al.
Nature Communications|December 8, 2025
Integration of multiple metabolic pathways supports high rates of carbon precipitation in living microbialitesRachel E Sipler, Eric W Isemonger, Samantha C Waterworth, et al.
American Journal of Clinical Pathology|June 22, 2021
Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant HistologyJoep J de Jong, Vikram M Narayan, Andrea A Cronican, et al.
Clinical Genitourinary Cancer|October 25, 2024
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 StudyMoritz J Reike, Daniele Raggi, Chiara Mercinelli, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2012
Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasiaEwan A Gibb, Daiana D Becker-Santos, Katey S S Enfield, et al.
Urologic Oncology|July 24, 2021
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibitionAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapyJoep J de Jong, Moritz J Reike, Yair Lotan, et al.
Genitourinary Medicine|April 1, 1997
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study GroupN J Bodsworth, R J Crooks, S Borelli, et al.
Scientific Reports|March 13, 2021
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancerFriedemann Krentel, Franziska Singer, María Lourdes Rosano-Gonzalez, et al.
British Journal of Cancer|October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicityA Gibb, A Greystoke, M Ranson, et al.
JCI Insight|February 9, 2018
TAK1 regulates skeletal muscle mass and mitochondrial functionSajedah M Hindi, Shuichi Sato, Guangyan Xiong, et al.
Nature Communications|December 8, 2025
Integration of multiple metabolic pathways supports high rates of carbon precipitation in living microbialitesRachel E Sipler, Eric W Isemonger, Samantha C Waterworth, et al.
American Journal of Clinical Pathology|June 22, 2021
Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant HistologyJoep J de Jong, Vikram M Narayan, Andrea A Cronican, et al.
Clinical Genitourinary Cancer|October 25, 2024
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 StudyMoritz J Reike, Daniele Raggi, Chiara Mercinelli, et al.
Pageof 21